nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—ALB—atherosclerosis	0.215	1	CbGaD
Mirabegron—SLCO1A2—Rosuvastatin—atherosclerosis	0.0858	0.142	CbGbCtD
Mirabegron—SLCO1A2—Simvastatin—atherosclerosis	0.0798	0.132	CbGbCtD
Mirabegron—SLCO1A2—Pravastatin—atherosclerosis	0.0781	0.129	CbGbCtD
Mirabegron—SLCO1A2—Lovastatin—atherosclerosis	0.0781	0.129	CbGbCtD
Mirabegron—ALB—Rosuvastatin—atherosclerosis	0.0443	0.0733	CbGbCtD
Mirabegron—CYP2D6—Niacin—atherosclerosis	0.0257	0.0425	CbGbCtD
Mirabegron—ABCB1—Ezetimibe—atherosclerosis	0.0232	0.0384	CbGbCtD
Mirabegron—ABCB1—Simvastatin—atherosclerosis	0.0216	0.0357	CbGbCtD
Mirabegron—ABCB1—Pravastatin—atherosclerosis	0.0211	0.0349	CbGbCtD
Mirabegron—ABCB1—Lovastatin—atherosclerosis	0.0211	0.0349	CbGbCtD
Mirabegron—CYP2D6—Simvastatin—atherosclerosis	0.0203	0.0336	CbGbCtD
Mirabegron—CYP2D6—Pravastatin—atherosclerosis	0.0199	0.0329	CbGbCtD
Mirabegron—CYP2D6—Lovastatin—atherosclerosis	0.0199	0.0329	CbGbCtD
Mirabegron—CYP3A4—Rosuvastatin—atherosclerosis	0.0139	0.023	CbGbCtD
Mirabegron—CYP3A4—Ezetimibe—atherosclerosis	0.0139	0.023	CbGbCtD
Mirabegron—CYP3A4—Simvastatin—atherosclerosis	0.0129	0.0214	CbGbCtD
Mirabegron—CYP3A4—Pravastatin—atherosclerosis	0.0126	0.0209	CbGbCtD
Mirabegron—CYP3A4—Lovastatin—atherosclerosis	0.0126	0.0209	CbGbCtD
Mirabegron—Gamma-glutamyltransferase increased—Ezetimibe—atherosclerosis	0.00177	0.0179	CcSEcCtD
Mirabegron—Glaucoma—Niacin—atherosclerosis	0.00169	0.0171	CcSEcCtD
Mirabegron—Gamma-glutamyltransferase increased—Pravastatin—atherosclerosis	0.00153	0.0154	CcSEcCtD
Mirabegron—Vascular purpura—Lovastatin—atherosclerosis	0.0012	0.0122	CcSEcCtD
Mirabegron—Vaginal infection—Niacin—atherosclerosis	0.0012	0.0122	CcSEcCtD
Mirabegron—Breast disorder—Rosuvastatin—atherosclerosis	0.00115	0.0116	CcSEcCtD
Mirabegron—Vascular purpura—Simvastatin—atherosclerosis	0.00113	0.0114	CcSEcCtD
Mirabegron—Purpura—Lovastatin—atherosclerosis	0.00112	0.0113	CcSEcCtD
Mirabegron—Influenza—Rosuvastatin—atherosclerosis	0.0011	0.0111	CcSEcCtD
Mirabegron—Atrial fibrillation—Simvastatin—atherosclerosis	0.00106	0.0108	CcSEcCtD
Mirabegron—Purpura—Simvastatin—atherosclerosis	0.00105	0.0106	CcSEcCtD
Mirabegron—Vascular purpura—Pravastatin—atherosclerosis	0.00102	0.0103	CcSEcCtD
Mirabegron—Atrial fibrillation—Niacin—atherosclerosis	0.000977	0.00987	CcSEcCtD
Mirabegron—Breast disorder—Ezetimibe—atherosclerosis	0.000955	0.00965	CcSEcCtD
Mirabegron—Urinary tract infection—Rosuvastatin—atherosclerosis	0.000953	0.00963	CcSEcCtD
Mirabegron—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.000952	0.00962	CcSEcCtD
Mirabegron—Purpura—Pravastatin—atherosclerosis	0.000946	0.00956	CcSEcCtD
Mirabegron—Nasopharyngitis—Ezetimibe—atherosclerosis	0.000945	0.00955	CcSEcCtD
Mirabegron—Gastritis—Ezetimibe—atherosclerosis	0.000936	0.00946	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.000932	0.00942	CcSEcCtD
Mirabegron—Influenza—Lovastatin—atherosclerosis	0.000931	0.00941	CcSEcCtD
Mirabegron—Sinusitis—Rosuvastatin—atherosclerosis	0.000919	0.00929	CcSEcCtD
Mirabegron—Influenza—Ezetimibe—atherosclerosis	0.000914	0.00923	CcSEcCtD
Mirabegron—Gastritis—Simvastatin—atherosclerosis	0.000892	0.00902	CcSEcCtD
Mirabegron—Rhinitis—Rosuvastatin—atherosclerosis	0.000882	0.00891	CcSEcCtD
Mirabegron—Urinary retention—Niacin—atherosclerosis	0.00088	0.0089	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000849	0.00858	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000823	0.00832	CcSEcCtD
Mirabegron—Nasopharyngitis—Pravastatin—atherosclerosis	0.000815	0.00824	CcSEcCtD
Mirabegron—Infestation NOS—Ezetimibe—atherosclerosis	0.000815	0.00823	CcSEcCtD
Mirabegron—Infestation—Ezetimibe—atherosclerosis	0.000815	0.00823	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.00081	0.00818	CcSEcCtD
Mirabegron—Urinary tract infection—Lovastatin—atherosclerosis	0.000807	0.00816	CcSEcCtD
Mirabegron—Abdominal distension—Niacin—atherosclerosis	0.000805	0.00814	CcSEcCtD
Mirabegron—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000804	0.00812	CcSEcCtD
Mirabegron—Influenza—Niacin—atherosclerosis	0.0008	0.00809	CcSEcCtD
Mirabegron—Abdominal distension—Pravastatin—atherosclerosis	0.000793	0.00802	CcSEcCtD
Mirabegron—Influenza—Pravastatin—atherosclerosis	0.000788	0.00796	CcSEcCtD
Mirabegron—Sinusitis—Lovastatin—atherosclerosis	0.000779	0.00788	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00077	0.00778	CcSEcCtD
Mirabegron—Sinusitis—Ezetimibe—atherosclerosis	0.000764	0.00772	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000732	0.0074	CcSEcCtD
Mirabegron—Sinusitis—Simvastatin—atherosclerosis	0.000729	0.00737	CcSEcCtD
Mirabegron—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000719	0.00726	CcSEcCtD
Mirabegron—Erythema multiforme—Lovastatin—atherosclerosis	0.000705	0.00713	CcSEcCtD
Mirabegron—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000696	0.00704	CcSEcCtD
Mirabegron—Erythema multiforme—Ezetimibe—atherosclerosis	0.000691	0.00699	CcSEcCtD
Mirabegron—Urinary tract infection—Pravastatin—atherosclerosis	0.000683	0.0069	CcSEcCtD
Mirabegron—Erythema multiforme—Simvastatin—atherosclerosis	0.000659	0.00666	CcSEcCtD
Mirabegron—Sinusitis—Pravastatin—atherosclerosis	0.000659	0.00666	CcSEcCtD
Mirabegron—Arthralgia—Rosuvastatin—atherosclerosis	0.000652	0.00659	CcSEcCtD
Mirabegron—Rhinitis—Niacin—atherosclerosis	0.000642	0.00649	CcSEcCtD
Mirabegron—Rhinitis—Pravastatin—atherosclerosis	0.000632	0.00639	CcSEcCtD
Mirabegron—Back pain—Lovastatin—atherosclerosis	0.000628	0.00635	CcSEcCtD
Mirabegron—Infection—Rosuvastatin—atherosclerosis	0.000621	0.00628	CcSEcCtD
Mirabegron—Back pain—Ezetimibe—atherosclerosis	0.000616	0.00622	CcSEcCtD
Mirabegron—Vision blurred—Lovastatin—atherosclerosis	0.000612	0.00618	CcSEcCtD
Mirabegron—Eye disorder—Niacin—atherosclerosis	0.000598	0.00605	CcSEcCtD
Mirabegron—Erythema multiforme—Pravastatin—atherosclerosis	0.000596	0.00603	CcSEcCtD
Mirabegron—Cardiac disorder—Pravastatin—atherosclerosis	0.000585	0.00591	CcSEcCtD
Mirabegron—Vision blurred—Simvastatin—atherosclerosis	0.000572	0.00578	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000569	0.00576	CcSEcCtD
Mirabegron—Palpitations—Ezetimibe—atherosclerosis	0.000563	0.00569	CcSEcCtD
Mirabegron—Arthralgia—Lovastatin—atherosclerosis	0.000553	0.00558	CcSEcCtD
Mirabegron—Dyspepsia—Rosuvastatin—atherosclerosis	0.00055	0.00556	CcSEcCtD
Mirabegron—Hypertension—Ezetimibe—atherosclerosis	0.00055	0.00556	CcSEcCtD
Mirabegron—Arthralgia—Ezetimibe—atherosclerosis	0.000542	0.00548	CcSEcCtD
Mirabegron—Dry mouth—Lovastatin—atherosclerosis	0.00054	0.00546	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000538	0.00544	CcSEcCtD
Mirabegron—Constipation—Rosuvastatin—atherosclerosis	0.000535	0.0054	CcSEcCtD
Mirabegron—Dry mouth—Ezetimibe—atherosclerosis	0.00053	0.00536	CcSEcCtD
Mirabegron—Infection—Lovastatin—atherosclerosis	0.000526	0.00532	CcSEcCtD
Mirabegron—Vision blurred—Niacin—atherosclerosis	0.000525	0.00531	CcSEcCtD
Mirabegron—Vision blurred—Pravastatin—atherosclerosis	0.000517	0.00523	CcSEcCtD
Mirabegron—Arthralgia—Simvastatin—atherosclerosis	0.000517	0.00522	CcSEcCtD
Mirabegron—Infection—Ezetimibe—atherosclerosis	0.000516	0.00522	CcSEcCtD
Mirabegron—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000511	0.00517	CcSEcCtD
Mirabegron—Skin disorder—Ezetimibe—atherosclerosis	0.000505	0.0051	CcSEcCtD
Mirabegron—Urticaria—Rosuvastatin—atherosclerosis	0.000497	0.00502	CcSEcCtD
Mirabegron—Abdominal pain—Rosuvastatin—atherosclerosis	0.000494	0.00499	CcSEcCtD
Mirabegron—Palpitations—Niacin—atherosclerosis	0.000493	0.00498	CcSEcCtD
Mirabegron—Infection—Simvastatin—atherosclerosis	0.000492	0.00498	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000483	0.00488	CcSEcCtD
Mirabegron—Arthralgia—Niacin—atherosclerosis	0.000475	0.0048	CcSEcCtD
Mirabegron—Hypertension—Pravastatin—atherosclerosis	0.000474	0.00479	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000473	0.00478	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000471	0.00476	CcSEcCtD
Mirabegron—Arthralgia—Pravastatin—atherosclerosis	0.000467	0.00472	CcSEcCtD
Mirabegron—Dyspepsia—Lovastatin—atherosclerosis	0.000466	0.00471	CcSEcCtD
Mirabegron—Dry mouth—Niacin—atherosclerosis	0.000464	0.00469	CcSEcCtD
Mirabegron—Dyspepsia—Ezetimibe—atherosclerosis	0.000457	0.00462	CcSEcCtD
Mirabegron—Fatigue—Lovastatin—atherosclerosis	0.000457	0.00462	CcSEcCtD
Mirabegron—Constipation—Lovastatin—atherosclerosis	0.000453	0.00458	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000451	0.00456	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000449	0.00453	CcSEcCtD
Mirabegron—Asthenia—Rosuvastatin—atherosclerosis	0.000448	0.00453	CcSEcCtD
Mirabegron—Fatigue—Ezetimibe—atherosclerosis	0.000448	0.00453	CcSEcCtD
Mirabegron—Infection—Pravastatin—atherosclerosis	0.000445	0.0045	CcSEcCtD
Mirabegron—Constipation—Ezetimibe—atherosclerosis	0.000444	0.00449	CcSEcCtD
Mirabegron—Tachycardia—Niacin—atherosclerosis	0.000444	0.00449	CcSEcCtD
Mirabegron—Pruritus—Rosuvastatin—atherosclerosis	0.000442	0.00447	CcSEcCtD
Mirabegron—Skin disorder—Niacin—atherosclerosis	0.000442	0.00447	CcSEcCtD
Mirabegron—Dyspepsia—Simvastatin—atherosclerosis	0.000436	0.00441	CcSEcCtD
Mirabegron—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000433	0.00438	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000428	0.00432	CcSEcCtD
Mirabegron—Diarrhoea—Rosuvastatin—atherosclerosis	0.000428	0.00432	CcSEcCtD
Mirabegron—Fatigue—Simvastatin—atherosclerosis	0.000427	0.00432	CcSEcCtD
Mirabegron—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000425	0.00429	CcSEcCtD
Mirabegron—Constipation—Simvastatin—atherosclerosis	0.000424	0.00428	CcSEcCtD
Mirabegron—Urticaria—Lovastatin—atherosclerosis	0.000421	0.00425	CcSEcCtD
Mirabegron—Abdominal pain—Lovastatin—atherosclerosis	0.000419	0.00423	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000414	0.00419	CcSEcCtD
Mirabegron—Dizziness—Rosuvastatin—atherosclerosis	0.000413	0.00418	CcSEcCtD
Mirabegron—Urticaria—Ezetimibe—atherosclerosis	0.000413	0.00417	CcSEcCtD
Mirabegron—Abdominal pain—Ezetimibe—atherosclerosis	0.000411	0.00415	CcSEcCtD
Mirabegron—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000408	0.00412	CcSEcCtD
Mirabegron—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000405	0.0041	CcSEcCtD
Mirabegron—Dyspepsia—Niacin—atherosclerosis	0.0004	0.00405	CcSEcCtD
Mirabegron—Dyspepsia—Pravastatin—atherosclerosis	0.000394	0.00399	CcSEcCtD
Mirabegron—Rash—Rosuvastatin—atherosclerosis	0.000394	0.00398	CcSEcCtD
Mirabegron—Dermatitis—Rosuvastatin—atherosclerosis	0.000394	0.00398	CcSEcCtD
Mirabegron—Urticaria—Simvastatin—atherosclerosis	0.000394	0.00398	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Niacin—atherosclerosis	0.000393	0.00397	CcSEcCtD
Mirabegron—Abdominal pain—Simvastatin—atherosclerosis	0.000392	0.00396	CcSEcCtD
Mirabegron—Headache—Rosuvastatin—atherosclerosis	0.000392	0.00396	CcSEcCtD
Mirabegron—Fatigue—Pravastatin—atherosclerosis	0.000386	0.0039	CcSEcCtD
Mirabegron—Constipation—Pravastatin—atherosclerosis	0.000383	0.00387	CcSEcCtD
Mirabegron—Asthenia—Lovastatin—atherosclerosis	0.00038	0.00384	CcSEcCtD
Mirabegron—Pruritus—Lovastatin—atherosclerosis	0.000375	0.00379	CcSEcCtD
Mirabegron—Asthenia—Ezetimibe—atherosclerosis	0.000373	0.00377	CcSEcCtD
Mirabegron—Gastrointestinal pain—Niacin—atherosclerosis	0.000372	0.00376	CcSEcCtD
Mirabegron—Nausea—Rosuvastatin—atherosclerosis	0.000371	0.00375	CcSEcCtD
Mirabegron—Pruritus—Ezetimibe—atherosclerosis	0.000368	0.00372	CcSEcCtD
Mirabegron—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000366	0.0037	CcSEcCtD
Mirabegron—Diarrhoea—Lovastatin—atherosclerosis	0.000362	0.00366	CcSEcCtD
Mirabegron—Urticaria—Niacin—atherosclerosis	0.000361	0.00365	CcSEcCtD
Mirabegron—Abdominal pain—Niacin—atherosclerosis	0.00036	0.00364	CcSEcCtD
Mirabegron—Urticaria—Pravastatin—atherosclerosis	0.000356	0.0036	CcSEcCtD
Mirabegron—Asthenia—Simvastatin—atherosclerosis	0.000355	0.00359	CcSEcCtD
Mirabegron—Diarrhoea—Ezetimibe—atherosclerosis	0.000355	0.00359	CcSEcCtD
Mirabegron—Abdominal pain—Pravastatin—atherosclerosis	0.000354	0.00358	CcSEcCtD
Mirabegron—Pruritus—Simvastatin—atherosclerosis	0.000351	0.00354	CcSEcCtD
Mirabegron—Dizziness—Lovastatin—atherosclerosis	0.00035	0.00354	CcSEcCtD
Mirabegron—Dizziness—Ezetimibe—atherosclerosis	0.000344	0.00347	CcSEcCtD
Mirabegron—Diarrhoea—Simvastatin—atherosclerosis	0.000339	0.00343	CcSEcCtD
Mirabegron—Rash—Lovastatin—atherosclerosis	0.000334	0.00338	CcSEcCtD
Mirabegron—Dermatitis—Lovastatin—atherosclerosis	0.000334	0.00337	CcSEcCtD
Mirabegron—Headache—Lovastatin—atherosclerosis	0.000332	0.00335	CcSEcCtD
Mirabegron—Dizziness—Simvastatin—atherosclerosis	0.000328	0.00331	CcSEcCtD
Mirabegron—Rash—Ezetimibe—atherosclerosis	0.000328	0.00331	CcSEcCtD
Mirabegron—Dermatitis—Ezetimibe—atherosclerosis	0.000327	0.00331	CcSEcCtD
Mirabegron—Asthenia—Niacin—atherosclerosis	0.000326	0.0033	CcSEcCtD
Mirabegron—Headache—Ezetimibe—atherosclerosis	0.000325	0.00329	CcSEcCtD
Mirabegron—Pruritus—Niacin—atherosclerosis	0.000322	0.00325	CcSEcCtD
Mirabegron—Asthenia—Pravastatin—atherosclerosis	0.000321	0.00325	CcSEcCtD
Mirabegron—Pruritus—Pravastatin—atherosclerosis	0.000317	0.0032	CcSEcCtD
Mirabegron—Nausea—Lovastatin—atherosclerosis	0.000315	0.00318	CcSEcCtD
Mirabegron—Rash—Simvastatin—atherosclerosis	0.000312	0.00316	CcSEcCtD
Mirabegron—Dermatitis—Simvastatin—atherosclerosis	0.000312	0.00315	CcSEcCtD
Mirabegron—Diarrhoea—Niacin—atherosclerosis	0.000311	0.00315	CcSEcCtD
Mirabegron—Headache—Simvastatin—atherosclerosis	0.00031	0.00314	CcSEcCtD
Mirabegron—Nausea—Ezetimibe—atherosclerosis	0.000309	0.00312	CcSEcCtD
Mirabegron—Diarrhoea—Pravastatin—atherosclerosis	0.000306	0.0031	CcSEcCtD
Mirabegron—Dizziness—Niacin—atherosclerosis	0.000301	0.00304	CcSEcCtD
Mirabegron—Dizziness—Pravastatin—atherosclerosis	0.000296	0.00299	CcSEcCtD
Mirabegron—Nausea—Simvastatin—atherosclerosis	0.000294	0.00297	CcSEcCtD
Mirabegron—Rash—Niacin—atherosclerosis	0.000287	0.0029	CcSEcCtD
Mirabegron—Dermatitis—Niacin—atherosclerosis	0.000287	0.0029	CcSEcCtD
Mirabegron—Headache—Niacin—atherosclerosis	0.000285	0.00288	CcSEcCtD
Mirabegron—Rash—Pravastatin—atherosclerosis	0.000282	0.00285	CcSEcCtD
Mirabegron—Dermatitis—Pravastatin—atherosclerosis	0.000282	0.00285	CcSEcCtD
Mirabegron—Headache—Pravastatin—atherosclerosis	0.000281	0.00284	CcSEcCtD
Mirabegron—Nausea—Niacin—atherosclerosis	0.00027	0.00273	CcSEcCtD
Mirabegron—Nausea—Pravastatin—atherosclerosis	0.000266	0.00269	CcSEcCtD
Mirabegron—ALB—Metabolism—LPA—atherosclerosis	1.57e-05	0.000194	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—CAV1—atherosclerosis	1.56e-05	0.000193	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—MAPK3—atherosclerosis	1.56e-05	0.000193	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—LPL—atherosclerosis	1.56e-05	0.000193	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.56e-05	0.000193	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—APOA1—atherosclerosis	1.56e-05	0.000192	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP7A1—atherosclerosis	1.55e-05	0.000192	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—AGT—atherosclerosis	1.55e-05	0.000191	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.54e-05	0.00019	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.52e-05	0.000188	CbGpPWpGaD
Mirabegron—ALB—Metabolism—BGN—atherosclerosis	1.52e-05	0.000188	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—GPX1—atherosclerosis	1.52e-05	0.000188	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—APOE—atherosclerosis	1.52e-05	0.000187	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—LEP—atherosclerosis	1.52e-05	0.000187	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—TGFB1—atherosclerosis	1.51e-05	0.000187	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	1.51e-05	0.000187	CbGpPWpGaD
Mirabegron—ALB—Metabolism—APOA5—atherosclerosis	1.51e-05	0.000186	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CAV1—atherosclerosis	1.5e-05	0.000186	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—APOA1—atherosclerosis	1.5e-05	0.000185	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—HMOX1—atherosclerosis	1.5e-05	0.000185	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.49e-05	0.000184	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.49e-05	0.000184	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—F2—atherosclerosis	1.49e-05	0.000184	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CD36—atherosclerosis	1.48e-05	0.000183	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—CXCL8—atherosclerosis	1.48e-05	0.000183	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—NOS2—atherosclerosis	1.47e-05	0.000181	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	1.46e-05	0.000181	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PLA2G1B—atherosclerosis	1.45e-05	0.000179	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ESR1—atherosclerosis	1.45e-05	0.000179	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOA2—atherosclerosis	1.44e-05	0.000178	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.44e-05	0.000178	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.44e-05	0.000178	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALOX15—atherosclerosis	1.44e-05	0.000178	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.44e-05	0.000178	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP27A1—atherosclerosis	1.44e-05	0.000177	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	1.43e-05	0.000177	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—APOB—atherosclerosis	1.43e-05	0.000177	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—F2—atherosclerosis	1.43e-05	0.000177	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ABCG5—atherosclerosis	1.43e-05	0.000176	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PIK3CG—atherosclerosis	1.42e-05	0.000176	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	1.42e-05	0.000176	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	1.42e-05	0.000175	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.42e-05	0.000175	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.42e-05	0.000175	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—MTHFR—atherosclerosis	1.4e-05	0.000173	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ALOX5—atherosclerosis	1.4e-05	0.000173	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GSTM1—atherosclerosis	1.39e-05	0.000172	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.39e-05	0.000172	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PPARA—atherosclerosis	1.38e-05	0.00017	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—LPA—atherosclerosis	1.38e-05	0.00017	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PIK3CG—atherosclerosis	1.37e-05	0.000169	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—LPL—atherosclerosis	1.37e-05	0.000169	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOA2—atherosclerosis	1.36e-05	0.000168	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALOX15—atherosclerosis	1.36e-05	0.000168	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALOX5AP—atherosclerosis	1.36e-05	0.000168	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PLA2G2A—atherosclerosis	1.36e-05	0.000168	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.35e-05	0.000167	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ABCG5—atherosclerosis	1.34e-05	0.000166	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GPX1—atherosclerosis	1.34e-05	0.000165	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—AGT—atherosclerosis	1.33e-05	0.000165	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—BGN—atherosclerosis	1.33e-05	0.000165	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOA5—atherosclerosis	1.32e-05	0.000163	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—MAPK3—atherosclerosis	1.31e-05	0.000162	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—APOE—atherosclerosis	1.31e-05	0.000162	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—IGF1—atherosclerosis	1.3e-05	0.000161	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CD36—atherosclerosis	1.3e-05	0.000161	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—LPA—atherosclerosis	1.3e-05	0.00016	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—INS—atherosclerosis	1.3e-05	0.00016	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CAV1—atherosclerosis	1.3e-05	0.00016	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.29e-05	0.00016	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—APOA1—atherosclerosis	1.29e-05	0.00016	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CCL2—atherosclerosis	1.27e-05	0.000157	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.27e-05	0.000157	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.26e-05	0.000156	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—BGN—atherosclerosis	1.26e-05	0.000155	CbGpPWpGaD
Mirabegron—ALB—Metabolism—NAMPT—atherosclerosis	1.26e-05	0.000155	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IGF1—atherosclerosis	1.25e-05	0.000155	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.25e-05	0.000154	CbGpPWpGaD
Mirabegron—ALB—Metabolism—LIPC—atherosclerosis	1.25e-05	0.000154	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOA5—atherosclerosis	1.24e-05	0.000154	CbGpPWpGaD
Mirabegron—ALB—Metabolism—APOC3—atherosclerosis	1.24e-05	0.000153	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—SERPINE1—atherosclerosis	1.24e-05	0.000153	CbGpPWpGaD
Mirabegron—ALB—Metabolism—LDLR—atherosclerosis	1.23e-05	0.000152	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—MTHFR—atherosclerosis	1.23e-05	0.000152	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALOX5—atherosclerosis	1.23e-05	0.000152	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PPARA—atherosclerosis	1.21e-05	0.000149	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CETP—atherosclerosis	1.2e-05	0.000149	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	1.2e-05	0.000148	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—SERPINE1—atherosclerosis	1.19e-05	0.000147	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.18e-05	0.000146	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—NOS3—atherosclerosis	1.18e-05	0.000146	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PIK3CG—atherosclerosis	1.18e-05	0.000146	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—AGT—atherosclerosis	1.17e-05	0.000145	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALOX5—atherosclerosis	1.16e-05	0.000143	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SCARB1—atherosclerosis	1.15e-05	0.000143	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—APOE—atherosclerosis	1.15e-05	0.000142	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PPARG—atherosclerosis	1.14e-05	0.000141	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CAV1—atherosclerosis	1.14e-05	0.00014	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NOS3—atherosclerosis	1.14e-05	0.00014	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—APOA1—atherosclerosis	1.13e-05	0.00014	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.12e-05	0.000138	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—INS—atherosclerosis	1.12e-05	0.000138	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NAMPT—atherosclerosis	1.1e-05	0.000136	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—LIPC—atherosclerosis	1.09e-05	0.000135	CbGpPWpGaD
Mirabegron—ALB—Metabolism—HMGCR—atherosclerosis	1.09e-05	0.000135	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOC3—atherosclerosis	1.09e-05	0.000134	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—LDLR—atherosclerosis	1.08e-05	0.000134	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CETP—atherosclerosis	1.06e-05	0.00013	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—FABP4—atherosclerosis	1.05e-05	0.00013	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LCAT—atherosclerosis	1.05e-05	0.00013	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	1.05e-05	0.00013	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NAMPT—atherosclerosis	1.04e-05	0.000128	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.04e-05	0.000128	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PIK3CG—atherosclerosis	1.04e-05	0.000128	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOA4—atherosclerosis	1.03e-05	0.000128	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—LIPC—atherosclerosis	1.03e-05	0.000127	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOC3—atherosclerosis	1.02e-05	0.000127	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—ALB—atherosclerosis	1.02e-05	0.000127	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—LDLR—atherosclerosis	1.02e-05	0.000126	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.02e-05	0.000125	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SCARB1—atherosclerosis	1.01e-05	0.000125	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—CXCL8—atherosclerosis	1.01e-05	0.000125	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PPARG—atherosclerosis	9.99e-06	0.000123	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CETP—atherosclerosis	9.95e-06	0.000123	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	9.83e-06	0.000121	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—INS—atherosclerosis	9.8e-06	0.000121	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—NOS3—atherosclerosis	9.79e-06	0.000121	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—AKT1—atherosclerosis	9.74e-06	0.00012	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ABCA1—atherosclerosis	9.71e-06	0.00012	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—IL6—atherosclerosis	9.58e-06	0.000118	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HMGCR—atherosclerosis	9.55e-06	0.000118	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SCARB1—atherosclerosis	9.53e-06	0.000118	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP27A1—atherosclerosis	9.38e-06	0.000116	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	9.36e-06	0.000116	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MMP9—atherosclerosis	9.12e-06	0.000113	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NFKB1—atherosclerosis	9.02e-06	0.000111	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HMGCR—atherosclerosis	9e-06	0.000111	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—ALB—atherosclerosis	8.98e-06	0.000111	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PTGS2—atherosclerosis	8.96e-06	0.000111	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	8.89e-06	0.00011	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOA2—atherosclerosis	8.89e-06	0.00011	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	8.89e-06	0.00011	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALOX15—atherosclerosis	8.89e-06	0.00011	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MAPK8—atherosclerosis	8.87e-06	0.00011	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—AKT1—atherosclerosis	8.84e-06	0.000109	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ABCG5—atherosclerosis	8.79e-06	0.000109	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—NOS3—atherosclerosis	8.59e-06	0.000106	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ABCA1—atherosclerosis	8.51e-06	0.000105	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—VEGFA—atherosclerosis	8.5e-06	0.000105	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LPA—atherosclerosis	8.49e-06	0.000105	CbGpPWpGaD
Mirabegron—ALB—Metabolism—HMOX1—atherosclerosis	8.33e-06	0.000103	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—BGN—atherosclerosis	8.22e-06	0.000102	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—VEGFA—atherosclerosis	8.19e-06	0.000101	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOA5—atherosclerosis	8.14e-06	0.000101	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—STAT3—atherosclerosis	8.11e-06	0.0001	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—MAPK3—atherosclerosis	8.04e-06	9.94e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ABCA1—atherosclerosis	8.02e-06	9.91e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—APOB—atherosclerosis	7.98e-06	9.86e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PTGS2—atherosclerosis	7.86e-06	9.71e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	7.83e-06	9.67e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—TGFB1—atherosclerosis	7.8e-06	9.64e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GSTM1—atherosclerosis	7.76e-06	9.59e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—MAPK3—atherosclerosis	7.74e-06	9.57e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—LPL—atherosclerosis	7.62e-06	9.41e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALOX5—atherosclerosis	7.56e-06	9.34e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TGFB1—atherosclerosis	7.51e-06	9.28e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GPX1—atherosclerosis	7.43e-06	9.19e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HMOX1—atherosclerosis	7.3e-06	9.02e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CD36—atherosclerosis	7.24e-06	8.95e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOB—atherosclerosis	6.99e-06	8.64e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HMOX1—atherosclerosis	6.88e-06	8.5e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—MTHFR—atherosclerosis	6.86e-06	8.48e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GSTM1—atherosclerosis	6.8e-06	8.4e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NAMPT—atherosclerosis	6.78e-06	8.38e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LIPC—atherosclerosis	6.74e-06	8.33e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPARA—atherosclerosis	6.73e-06	8.32e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOC3—atherosclerosis	6.7e-06	8.28e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—LPL—atherosclerosis	6.68e-06	8.25e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LDLR—atherosclerosis	6.66e-06	8.23e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOB—atherosclerosis	6.59e-06	8.14e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AGT—atherosclerosis	6.52e-06	8.05e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GPX1—atherosclerosis	6.51e-06	8.05e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CETP—atherosclerosis	6.5e-06	8.03e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GSTM1—atherosclerosis	6.41e-06	7.92e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—APOE—atherosclerosis	6.39e-06	7.89e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CD36—atherosclerosis	6.34e-06	7.84e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CAV1—atherosclerosis	6.33e-06	7.82e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—APOA1—atherosclerosis	6.31e-06	7.8e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—LPL—atherosclerosis	6.29e-06	7.77e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SCARB1—atherosclerosis	6.23e-06	7.69e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GPX1—atherosclerosis	6.14e-06	7.58e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—MTHFR—atherosclerosis	6.01e-06	7.43e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CD36—atherosclerosis	5.98e-06	7.39e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPARA—atherosclerosis	5.9e-06	7.29e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HMGCR—atherosclerosis	5.88e-06	7.27e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PIK3CG—atherosclerosis	5.76e-06	7.12e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AGT—atherosclerosis	5.71e-06	7.06e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—MTHFR—atherosclerosis	5.67e-06	7e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL6—atherosclerosis	5.66e-06	6.99e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOE—atherosclerosis	5.6e-06	6.91e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPARG—atherosclerosis	5.56e-06	6.87e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPARA—atherosclerosis	5.56e-06	6.87e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CAV1—atherosclerosis	5.55e-06	6.85e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—APOA1—atherosclerosis	5.53e-06	6.84e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—INS—atherosclerosis	5.46e-06	6.74e-05	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—AKT1—atherosclerosis	5.43e-06	6.7e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AGT—atherosclerosis	5.38e-06	6.65e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOE—atherosclerosis	5.27e-06	6.52e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ABCA1—atherosclerosis	5.24e-06	6.48e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CAV1—atherosclerosis	5.23e-06	6.46e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—AKT1—atherosclerosis	5.22e-06	6.45e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—APOA1—atherosclerosis	5.21e-06	6.44e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PIK3CG—atherosclerosis	5.05e-06	6.24e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPARG—atherosclerosis	4.87e-06	6.02e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—NOS3—atherosclerosis	4.79e-06	5.91e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—INS—atherosclerosis	4.78e-06	5.91e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PIK3CG—atherosclerosis	4.76e-06	5.88e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPARG—atherosclerosis	4.59e-06	5.68e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—INS—atherosclerosis	4.51e-06	5.57e-05	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—AKT1—atherosclerosis	4.5e-06	5.56e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HMOX1—atherosclerosis	4.5e-06	5.56e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ALB—atherosclerosis	4.38e-06	5.42e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PTGS2—atherosclerosis	4.38e-06	5.41e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOB—atherosclerosis	4.31e-06	5.32e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NOS3—atherosclerosis	4.19e-06	5.18e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GSTM1—atherosclerosis	4.19e-06	5.18e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ALB—atherosclerosis	4.13e-06	5.1e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LPL—atherosclerosis	4.11e-06	5.08e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GPX1—atherosclerosis	4.01e-06	4.96e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NOS3—atherosclerosis	3.95e-06	4.88e-05	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—AKT1—atherosclerosis	3.95e-06	4.88e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CD36—atherosclerosis	3.91e-06	4.83e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PTGS2—atherosclerosis	3.83e-06	4.74e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MTHFR—atherosclerosis	3.7e-06	4.58e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPARA—atherosclerosis	3.63e-06	4.49e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PTGS2—atherosclerosis	3.61e-06	4.46e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AGT—atherosclerosis	3.52e-06	4.35e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOE—atherosclerosis	3.45e-06	4.26e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CAV1—atherosclerosis	3.42e-06	4.22e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—APOA1—atherosclerosis	3.41e-06	4.21e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.11e-06	3.84e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPARG—atherosclerosis	3e-06	3.71e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—INS—atherosclerosis	2.95e-06	3.64e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ALB—atherosclerosis	2.7e-06	3.34e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NOS3—atherosclerosis	2.58e-06	3.19e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.36e-06	2.92e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AKT1—atherosclerosis	2.2e-06	2.72e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AKT1—atherosclerosis	1.93e-06	2.38e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AKT1—atherosclerosis	1.82e-06	2.24e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AKT1—atherosclerosis	1.19e-06	1.47e-05	CbGpPWpGaD
